CD8A and chronic myelogenous leukemia, BCR-ABL1 positive: The results obtained in mice were confirmed in comparable experiments using Treg, CML stem/progenitor cells and CD8+ CTLs from newly diagnosed CML patients and suggest a similar role of Tregs in the protection of LSCs from CD8+ CTLs–mediated killing in humans.